Quartz·1 min read·medium
Doctors and the FDA are raising alarms over compounded weight loss drugs
✦AI Summary
The FDA has issued 25 warning letters to telehealth companies regarding misleading marketing claims about compounded weight loss drugs. These drugs are often marketed as alternatives to popular medications like Ozempic.
The FDA issued 25 warning letters to telehealth companies last month over misleading claims about compounded versions of drugs like Ozempic
healthbusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in